Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications.

Hak E, Verheij TJ, Grobbee DE, Nichol KL, Hoes AW.

J Epidemiol Community Health. 2002 Dec;56(12):951-5. Review.

2.

Confounding in evaluating the effectiveness of influenza vaccine.

Mori M, Oura A, Ohnishi H, Washio M.

Vaccine. 2008 Nov 25;26(50):6459-61. doi: 10.1016/j.vaccine.2008.06.040. Epub 2008 Jun 23. Review.

PMID:
18573295
3.
4.

Essential tools for assessing influenza vaccine efficacy in improperly conducted studies: a Japanese perspective.

Hirota Y, Fukushima W, Fujieda M, Ohfuji S, Maeda A.

Vaccine. 2008 Nov 25;26(50):6455-8. doi: 10.1016/j.vaccine.2008.06.041. Epub 2008 Jun 23. Review.

PMID:
18573291
5.

New vaccine approaches for seasonal and pandemic influenza.

Palache B.

Vaccine. 2008 Nov 18;26(49):6232-6. doi: 10.1016/j.vaccine.2008.07.022. Epub 2008 Jul 30. Review.

PMID:
18674583
6.

Evaluating non-randomised intervention studies.

Deeks JJ, Dinnes J, D'Amico R, Sowden AJ, Sakarovitch C, Song F, Petticrew M, Altman DG; International Stroke Trial Collaborative Group.; European Carotid Surgery Trial Collaborative Group..

Health Technol Assess. 2003;7(27):iii-x, 1-173. Review.

7.

Is influenza vaccination in asthma helpful?

Bueving HJ, Thomas S, Wouden JC.

Curr Opin Allergy Clin Immunol. 2005 Feb;5(1):65-70. Review.

PMID:
15643346
8.

Trivalent intranasal influenza vaccine, live.

McCarthy MW, Kockler DR.

Ann Pharmacother. 2004 Dec;38(12):2086-93. Epub 2004 Oct 19. Review.

PMID:
15494383
9.

Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors.

Jackson LA, Nelson JC, Benson P, Neuzil KM, Reid RJ, Psaty BM, Heckbert SR, Larson EB, Weiss NS.

Int J Epidemiol. 2006 Apr;35(2):345-52. Epub 2005 Dec 20. Review.

PMID:
16368724
10.

Is influenza vaccination in asthmatic children helpful?

Bueving HJ.

Clin Exp Allergy. 2006 Jan;36(1):21-5. Review.

PMID:
16393261
11.

Systematic review and economic decision modelling for the prevention and treatment of influenza A and B.

Turner D, Wailoo A, Nicholson K, Cooper N, Sutton A, Abrams K.

Health Technol Assess. 2003;7(35):iii-iv, xi-xiii, 1-170. Review.

12.

Reduced-dose influenza vaccine.

Wyatt KN, Ryan GJ, Sheerin KA.

Ann Pharmacother. 2006 Sep;40(9):1635-9. Epub 2006 Jul 11. Review.

PMID:
16835314
13.
14.

The effect of misclassification on evaluating the effectiveness of influenza vaccines.

Ozasa K.

Vaccine. 2008 Nov 25;26(50):6462-5. doi: 10.1016/j.vaccine.2008.06.039. Epub 2008 Jun 23. Review.

PMID:
18573297
15.

[Influenza vaccine for all the elderly!].

Ligthart GJ.

Ned Tijdschr Geneeskd. 1995 Oct 21;139(42):2125-7. Review. Dutch. No abstract available.

PMID:
7477575
16.

Vaccine trials.

Farrington CP, Miller E.

Mol Biotechnol. 2001 Jan;17(1):43-58. Review.

PMID:
11280930
17.

Adjustments for center in multicenter studies: an overview.

Localio AR, Berlin JA, Ten Have TR, Kimmel SE.

Ann Intern Med. 2001 Jul 17;135(2):112-23. Review.

PMID:
11453711
18.

Statistical considerations for noninferiority/equivalence trials in vaccine development.

Wang WW, Mehrotra DV, Chan IS, Heyse JF.

J Biopharm Stat. 2006;16(4):429-41. Review.

PMID:
16892905
19.

Overview of vaccine field studies: types of effects and designs.

Halloran ME.

J Biopharm Stat. 2006;16(4):415-27. Review.

PMID:
16892904
20.

Crossover studies: a modified analysis with more power.

Cleophas TJ.

Clin Pharmacol Ther. 1993 May;53(5):515-20. Review. No abstract available.

PMID:
8491062

Supplemental Content

Support Center